AVITA Medical, Inc. (RCEL)

AVITA Medical Cash Flow Statement

Financials in millions AUD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-35.38	-26.67	-25.14	-42.03	-25.1
Depreciation & Amortization	1.38	1.26	0.66	0.97	0.27
Share-Based Compensation	8.38	7	3.59	16.59	1.95
Other Operating Activities	-12.39	-0.68	15.4	1.72	3.64
Operating Cash Flow	-38.01	-19.09	-5.5	-22.75	-19.25
Capital Expenditures	-1.38	-0.45	-0.07	-0.59	-1.02
Change in Investments	3.05	-18.81	-49.55	0	0
Other Investing Activities	-0.07	-0.07	-0.07	-0.26	-0.21
Investing Cash Flow	1.61	-19.33	-49.68	-0.85	-1.23
Share Issuance / Repurchase	1.61	0.9	0.01	82.18	32.71
Debt Issued / Paid	38.76	0	0	-0.04	-0.06
Other Financing Activities	-	-	-	-5.08	-2.93
Financing Cash Flow	40.37	0.9	0.01	77.06	29.71
Exchange Rate Effect	-0.02	-0.03	-0.06	0	0.16
Net Cash Flow	3.95	-37.55	-55.24	53.47	9.39
Free Cash Flow	-39.39	-19.54	-5.57	-23.34	-20.27
Free Cash Flow Margin	-76.38%	-51.92%	-16.08%	-128.30%	-177.89%
Free Cash Flow Per Share	-1.55	-0.78	-0.22	-1.15	-1.26

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).